NO20091562L - 2-aryl-6-fenylimidazol{1,2-alpha}pyridin derivater, femstilling derav samt terapeutisk anvendelse derav - Google Patents

2-aryl-6-fenylimidazol{1,2-alpha}pyridin derivater, femstilling derav samt terapeutisk anvendelse derav

Info

Publication number: NO20091562L
Authority: NO; Norway
Prior art keywords: optionally substituted; aryl; cycloalkyl; phenylimidazole; alpha
Prior art date: 2006-09-22

Application number

NO20091562A

Other languages

English (en)

Norwegian (no)

Inventor

Antonio Garcia Almario

Patrick A C Lardenois

Anne Olivier

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-22

Filing date

2009-04-20

Publication date

2009-04-20

2009-04-20 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2009-04-20 Publication of NO20091562L publication Critical patent/NO20091562L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Transplantation (AREA)
Psychology (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20091562A 2006-09-22 2009-04-20 2-aryl-6-fenylimidazol{1,2-alpha}pyridin derivater, femstilling derav samt terapeutisk anvendelse derav NO20091562L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0608350A FR2906250B1 (fr)	2006-09-22	2006-09-22	Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
PCT/FR2007/001517 WO2008034974A1 (fr)	2006-09-22	2007-09-19	DERIVES DE 2-ARYL-6-PHENYL-IMIDAZO[1,2-α]PYRIDINES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number	Publication Date
NO20091562L true NO20091562L (no)	2009-04-20

Family

ID=37841968

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20091562A NO20091562L (no)	2006-09-22	2009-04-20	2-aryl-6-fenylimidazol{1,2-alpha}pyridin derivater, femstilling derav samt terapeutisk anvendelse derav

Country Status (43)

Country	Link
US (1)	US7915284B2 (es)
EP (1)	EP2069342B1 (es)
JP (1)	JP5336378B2 (es)
KR (1)	KR101470039B1 (es)
CN (1)	CN101516881B (es)
AR (1)	AR062897A1 (es)
AT (1)	ATE467633T1 (es)
AU (1)	AU2007298856B2 (es)
BR (1)	BRPI0718517A2 (es)
CA (1)	CA2662848C (es)
CL (1)	CL2007002733A1 (es)
CO (1)	CO6160308A2 (es)
CR (1)	CR10643A (es)
CY (1)	CY1110232T1 (es)
DE (1)	DE602007006525D1 (es)
DK (1)	DK2069342T3 (es)
EA (1)	EA017442B1 (es)
ES (1)	ES2345016T3 (es)
FR (1)	FR2906250B1 (es)
GT (1)	GT200900049A (es)
HN (1)	HN2009000502A (es)
HR (1)	HRP20100408T1 (es)
IL (1)	IL197352A (es)
JO (1)	JO2643B1 (es)
MA (1)	MA30792B1 (es)
ME (1)	MEP10709A (es)
MX (1)	MX2009002802A (es)
MY (1)	MY145603A (es)
NI (1)	NI200900037A (es)
NO (1)	NO20091562L (es)
NZ (1)	NZ575337A (es)
PE (1)	PE20080671A1 (es)
PL (1)	PL2069342T3 (es)
PT (1)	PT2069342E (es)
RS (1)	RS51412B (es)
SI (1)	SI2069342T1 (es)
SV (1)	SV2009003193A (es)
TN (1)	TN2009000081A1 (es)
TW (1)	TWI381837B (es)
UA (1)	UA95976C2 (es)
UY (1)	UY30603A1 (es)
WO (1)	WO2008034974A1 (es)
ZA (1)	ZA200901551B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2928923B1 (fr) *	2008-03-21	2010-04-23	Sanofi Aventis	Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques
FR2928921B1 (fr) *	2008-03-21	2010-04-23	Sanofi Aventis	Derives polysubstitues de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines, leur preparation et leur application en therapeutique
FR2928922B1 (fr) *	2008-03-21	2010-04-23	Sanofi Aventis	Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
FR2928924B1 (fr)	2008-03-21	2010-04-23	Sanofi Aventis	Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
FR2933609B1 (fr) *	2008-07-10	2010-08-27	Fournier Lab Sa	Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson.
FR2950344B1 (fr) *	2009-09-18	2011-11-25	Sanofi Aventis	Derives de 5-phenyl-pyrazolopyridine, leur preparation et leur aplication en therapeutique.
FR2950345B1 (fr) *	2009-09-18	2011-09-23	Sanofi Aventis	Derives acetyleniques de 5-phenyl-pyrazolopyridine, leur preparation et leur application en therapeutique
FR2953520B1 (fr) *	2009-12-04	2011-11-25	Sanofi Aventis	Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique
CA2884956A1 (en) *	2012-11-29	2014-06-05	F. Hoffmann-La Roche Ag	Imidazopyridine derivatives
US9745328B2 (en)	2013-02-04	2017-08-29	Janssen Pharmaceutica Nv	Flap modulators
TWI644899B (zh)	2013-02-04	2018-12-21	健生藥品公司	Ｆｌａｐ調節劑
US20160185774A1 (en) *	2013-08-02	2016-06-30	Institut Pasteur Korea	Anti-Infective Compounds
WO2016161960A1 (en)	2015-04-10	2016-10-13	Beigene, Ltd.	NOVEL 5 OR 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES
MA52119A (fr)	2015-10-19	2018-08-29	Ncyte Corp	Composés hétérocycliques utilisés comme immunomodulateurs
MY199220A (en)	2015-11-19	2023-10-20	Incyte Corp	Heterocyclic compounds as immunomodulators
JP6911031B2 (ja)	2015-12-22	2021-07-28	インサイト・コーポレイションＩｎｃｙｔｅＣｏｒｐｏｒａｔｉｏｎ	免疫調節剤としての複素環化合物
TW201808950A (zh)	2016-05-06	2018-03-16	英塞特公司	作為免疫調節劑之雜環化合物
US20170342060A1 (en)	2016-05-26	2017-11-30	Incyte Corporation	Heterocyclic compounds as immunomodulators
MY197280A (en)	2016-06-20	2023-06-09	Incyte Corp	Heterocyclic compounds as immunomodulators
EP3484866B1 (en)	2016-07-14	2022-09-07	Incyte Corporation	Heterocyclic compounds as immunomodulators
MA46045A (fr)	2016-08-29	2021-04-28	Incyte Corp	Composés hétérocycliques utilisés comme immunomodulateurs
CN109952300B (zh) *	2016-09-24	2022-01-18	百济神州有限公司	5或8-取代的咪唑并[1,5-a]吡啶
PT3558990T (pt)	2016-12-22	2022-11-21	Incyte Corp	Derivados de tetrahidroimidazo[4,5-c]piridina como indutores da internalização de pd-l1
BR112019012993A2 (pt)	2016-12-22	2019-12-03	Incyte Corporation	derivados de benzo-oxazol como imunomoduladores
US20180179201A1 (en)	2016-12-22	2018-06-28	Incyte Corporation	Heterocyclic compounds as immunomodulators
MA47099A (fr)	2016-12-22	2021-05-12	Incyte Corp	Composés hétéroaromatiques bicycliques utilisés en tant qu'immunomodulateurs
ES2899402T3 (es)	2016-12-22	2022-03-11	Incyte Corp	Derivados de piridina como inmunomoduladores
US11472788B2 (en)	2017-11-25	2022-10-18	Beigene, Ltd.	Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenases
HRP20230090T1 (hr)	2018-03-30	2023-03-17	Incyte Corporation	Heterociklički spojevi kao imunomodulatori
HUE061503T2 (hu)	2018-05-11	2023-07-28	Incyte Corp	Tetrahidro-imidazo[4,5-C]piridin-származékok mint PD-L1 immunmodulátorok
US11753406B2 (en)	2019-08-09	2023-09-12	Incyte Corporation	Salts of a PD-1/PD-L1 inhibitor
PH12022550754A1 (en)	2019-09-30	2023-08-23	Incyte Corp	Pyrido[3,2-d]pyrimidine compounds as immunomodulators
AU2020385113A1 (en)	2019-11-11	2022-05-19	Incyte Corporation	Salts and crystalline forms of a PD-1/PD-L1 inhibitor
EP4058065A4 (en) *	2019-11-13	2023-05-03	Aprinoia Therapeutics Limited	COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES THEREOF
TW202233615A (zh)	2020-11-06	2022-09-01	美商英塞特公司	Ｐｄ—１／ｐｄ—ｌ１抑制劑之結晶形式
WO2022099018A1 (en)	2020-11-06	2022-05-12	Incyte Corporation	Process of preparing a pd-1/pd-l1 inhibitor
MX2023005362A (es)	2020-11-06	2023-06-22	Incyte Corp	Proceso para hacer un inhibidor de proteina de muerte programada 1 (pd-1)/ligando de muerte programada 1 (pd-l1) y sales y formas cristalinas del mismo.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4041624B2 (ja) *	1999-07-21	2008-01-30	三井化学株式会社	有機電界発光素子
AU2001249672A1 (en) *	2000-03-31	2001-10-15	Ortho-Mcneil Pharmaceutical, Inc.	Method for using 2- or 3-aryl substituted imidazo(1,2-a) pyridines as h3 antagonists
GB0119911D0 (en) *	2001-08-15	2001-10-10	Novartis Ag	Organic Compounds
MXPA05003058A (es) *	2002-09-19	2005-05-27	Schering Corp	Nuevas imidazopiridinas como inhibidores de cinasa dependientes de ciclina.
GB0303503D0 (en) *	2003-02-14	2003-03-19	Novartis Ag	Organic compounds
CA2554554A1 (en) *	2004-03-08	2005-09-22	The University Of North Carolina At Chapel Hill	Novel dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2a]pyridines as antiprotozoal agents

2006
- 2006-09-22 FR FR0608350A patent/FR2906250B1/fr active Active
2007
- 2007-09-13 TW TW096134253A patent/TWI381837B/zh not_active IP Right Cessation
- 2007-09-19 NZ NZ575337A patent/NZ575337A/en not_active IP Right Cessation
- 2007-09-19 AR ARP070104136A patent/AR062897A1/es not_active Application Discontinuation
- 2007-09-19 EP EP07848251A patent/EP2069342B1/fr active Active
- 2007-09-19 BR BRPI0718517-0A patent/BRPI0718517A2/pt active Search and Examination
- 2007-09-19 KR KR1020097005741A patent/KR101470039B1/ko not_active Expired - Fee Related
- 2007-09-19 DK DK07848251.0T patent/DK2069342T3/da active
- 2007-09-19 DE DE602007006525T patent/DE602007006525D1/de active Active
- 2007-09-19 AU AU2007298856A patent/AU2007298856B2/en not_active Ceased
- 2007-09-19 ES ES07848251T patent/ES2345016T3/es active Active
- 2007-09-19 HR HR20100408T patent/HRP20100408T1/hr unknown
- 2007-09-19 ME MEP-107/09A patent/MEP10709A/xx unknown
- 2007-09-19 SI SI200730316T patent/SI2069342T1/sl unknown
- 2007-09-19 UA UAA200903928A patent/UA95976C2/ru unknown
- 2007-09-19 EA EA200970311A patent/EA017442B1/ru not_active IP Right Cessation
- 2007-09-19 PL PL07848251T patent/PL2069342T3/pl unknown
- 2007-09-19 PT PT07848251T patent/PT2069342E/pt unknown
- 2007-09-19 JP JP2009528752A patent/JP5336378B2/ja not_active Expired - Fee Related
- 2007-09-19 CN CN2007800352403A patent/CN101516881B/zh not_active Expired - Fee Related
- 2007-09-19 WO PCT/FR2007/001517 patent/WO2008034974A1/fr not_active Ceased
- 2007-09-19 AT AT07848251T patent/ATE467633T1/de active
- 2007-09-19 MY MYPI20091157A patent/MY145603A/en unknown
- 2007-09-19 RS RSP-2010/0356A patent/RS51412B/sr unknown
- 2007-09-19 ZA ZA200901551A patent/ZA200901551B/xx unknown
- 2007-09-19 MX MX2009002802A patent/MX2009002802A/es active IP Right Grant
- 2007-09-19 CA CA2662848A patent/CA2662848C/fr not_active Expired - Fee Related
- 2007-09-20 JO JO2007401A patent/JO2643B1/en active
- 2007-09-20 PE PE2007001266A patent/PE20080671A1/es not_active Application Discontinuation
- 2007-09-21 UY UY30603A patent/UY30603A1/es not_active Application Discontinuation
- 2007-09-21 CL CL200702733A patent/CL2007002733A1/es unknown
2009
- 2009-02-26 CR CR10643A patent/CR10643A/es unknown
- 2009-03-02 IL IL197352A patent/IL197352A/en not_active IP Right Cessation
- 2009-03-05 GT GT200900049A patent/GT200900049A/es unknown
- 2009-03-10 TN TN2009000081A patent/TN2009000081A1/fr unknown
- 2009-03-18 HN HN2009000502A patent/HN2009000502A/es unknown
- 2009-03-19 US US12/407,449 patent/US7915284B2/en not_active Expired - Fee Related
- 2009-03-19 NI NI200900037A patent/NI200900037A/es unknown
- 2009-03-19 SV SV2009003193A patent/SV2009003193A/es active IP Right Grant
- 2009-03-19 CO CO09028759A patent/CO6160308A2/es unknown
- 2009-04-16 MA MA31788A patent/MA30792B1/fr unknown
- 2009-04-20 NO NO20091562A patent/NO20091562L/no not_active Application Discontinuation
2010
- 2010-07-20 CY CY20101100678T patent/CY1110232T1/el unknown

Also Published As

Publication number	Publication date
CN101516881B (zh)	2012-07-18
RS51412B (sr)	2011-02-28
PE20080671A1 (es)	2008-07-14
HN2009000502A (es)	2011-07-11
JP2010504309A (ja)	2010-02-12
TW200833329A (en)	2008-08-16
IL197352A (en)	2014-11-30
ZA200901551B (en)	2010-06-30
FR2906250A1 (fr)	2008-03-28
JO2643B1 (en)	2012-06-17
CO6160308A2 (es)	2010-05-20
KR20090054449A (ko)	2009-05-29
JP5336378B2 (ja)	2013-11-06
UY30603A1 (es)	2008-05-02
EA017442B1 (ru)	2012-12-28
WO2008034974A1 (fr)	2008-03-27
US7915284B2 (en)	2011-03-29
EA200970311A1 (ru)	2009-08-28
EP2069342A1 (fr)	2009-06-17
DK2069342T3 (da)	2010-08-23
PL2069342T3 (pl)	2010-10-29
MY145603A (en)	2012-03-15
US20090253735A1 (en)	2009-10-08
SV2009003193A (es)	2010-02-01
EP2069342B1 (fr)	2010-05-12
AU2007298856A1 (en)	2008-03-27
AR062897A1 (es)	2008-12-10
BRPI0718517A2 (pt)	2013-11-19
KR101470039B1 (ko)	2014-12-05
NI200900037A (es)	2014-02-20
MA30792B1 (fr)	2009-10-01
ATE467633T1 (de)	2010-05-15
UA95976C2 (en)	2011-09-26
CR10643A (es)	2009-04-29
FR2906250B1 (fr)	2008-10-31
CL2007002733A1 (es)	2008-04-11
CA2662848C (fr)	2014-12-23
CA2662848A1 (fr)	2008-03-27
DE602007006525D1 (de)	2010-06-24
CN101516881A (zh)	2009-08-26
GT200900049A (es)	2010-03-04
NZ575337A (en)	2011-12-22
TN2009000081A1 (en)	2010-08-19
TWI381837B (zh)	2013-01-11
ME00615B (me)	2011-12-20
IL197352A0 (en)	2009-12-24
AU2007298856B2 (en)	2012-08-09
MX2009002802A (es)	2009-04-01
ES2345016T3 (es)	2010-09-13
SI2069342T1 (sl)	2010-09-30
CY1110232T1 (el)	2015-01-14
HRP20100408T1 (hr)	2010-09-30
PT2069342E (pt)	2010-07-19
MEP10709A (en)	2011-12-20
HK1135388A1 (en)	2010-06-04

Publication	Publication Date	Title
NO20091562L (no)	2009-04-20	2-aryl-6-fenylimidazol{1,2-alpha}pyridin derivater, femstilling derav samt terapeutisk anvendelse derav
MA32246B1 (fr)	2011-04-01	Dérivés polysubstitues de 2-aryl-6-phenyl-imidazo[1,2- a]pyridines, leur préparation et leur application en thérapeutique
MA32247B1 (fr)	2011-04-01	Derives de 2-aryl-6-phenyl-imidazo[1,2-a]pyridines polysubstitues, leur préparation et leur application en thérapeutique
CO6341631A2 (es)	2011-11-21	Derivados de 1,2,4 - oxadiazol y su uso terapéutico
ECSP077274A (es)	2007-03-29	Derivados de n-2 adamantanil-2-fenoxi-acetamida como inhibidores de deshidrogenasa 11-beta hidroxiesteroide
TW200942541A (en)	2009-10-16	Polysubstituted 6-heteroarylimidazo[1,2-α]pyridine derivatives, preparation thereof and therapeutic use thereof
EA201170099A1 (ru)	2011-08-30	Замещенные пиримидин-4-оновые производные
CY1111868T1 (el)	2015-11-04	Παραγωγα ιμιδαζο[1,2-α] πυριδινο-2-καρβοξαμιδιων η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
MX2012015023A (es)	2013-04-03	Derivado novedoso de nicotinamida o sal del mismo.
EA200870192A1 (ru)	2009-12-30	Новые серосодержащие производные циклической мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназ
CY1108025T1 (el)	2013-09-04	Παραγωγα n-[φαινυλο (πιπεριδινο-2-υλο)μεθυλο] βενζαμιδιου, η διαδικασια παρασκευης τους και η εφαρμογη τους στη θεραπευτικη
EA201170093A1 (ru)	2011-06-30	Замещенные n-оксидпиразиновые производные
MX2009012380A (es)	2009-12-03	Compuestos de heteroarilamida pirimidona.
NO20064326L (no)	2006-09-25	Aryl- og heteroarylpiperidinkarboksylatderivater, deres fremstilling og anvendelse derav i form av FAAH enzyminhibitorer
MX2009011212A (es)	2009-11-02	Derivados de triazolopiridina carboxamida y triazolopirimidina carboxamida, su preparacion y su aplicacion terapeutica.
MX2010008360A (es)	2010-08-30	Derivados de oxazepinopirimidona heteroarilamida sustituidos.
ATE478054T1 (de)	2010-09-15	Benzimidazolderivate
HRP20050628A2 (en)	2006-07-31	Substituted benzoyl derivatives uses as herbicides
MA32884B1 (fr)	2011-12-01	Derives de carbamates d'alkyl-heterocycles, leur preparation et leur application en therapeutique
EA201170097A1 (ru)	2011-08-30	Замещенные трициклические производные против нейродегенеративных заболеваний
CY1115138T1 (el)	2016-12-14	Παραγωγο 3,8-διαμινοτετραϋδροκινολινης
EA200700891A1 (ru)	2007-08-31	Производные пиридина, их получение и их применение в терапии
ES2184712T3 (es)	2003-04-16	Nuevos derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su utilizacion a titulo de medicamento.
NO20090269L (no)	2009-02-27	Fenolpentadienoylderivater og deres anvendelse som PAR-1-antagonister
ATE446305T1 (de)	2009-11-15	Neue 5-thioxylpyranose-derivate

Legal Events

Date	Code	Title	Description
2018-04-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application